Mama-Match
MEDVi review
⛔ Carries an FDA warning letter for a misbranded compounded product (#721455, February 2026). It names its pharmacies with addresses, but publishes only the first month's price.
- HSA / FSA eligible
- Independently scored
- No insurance needed
Every medical claim is cited to its primary source — the clinical trial or the FDA label — so you can open it and check it yourself. No one on this team is your healthcare professional. What follows is friendly information, never medical advice.
Gentler first steps than MEDVi
Providers we'd send a friend to, with the ones we work with listed first — CoreAge Rx leads our ranking on the score. Some of these links earn MamaGLP a referral commission.
- Meet CoreAge RxCoreAge RxOur #1 pick
$99/mo semaglutide, $149/mo tirzepatide, one flat price with both medications in a single account — and an intake that walks you through it instead of cornering you with a quiz.
- Meet Synergy Rx
$199–299/mo semaglutide, $349–399/mo tirzepatide depending on form, plus brand options, all published on its products page with no consult required.
- Meet Strut Health
$149/mo injectable semaglutide, $99/mo oral lozenge, $325/mo tirzepatide ($199 on auto-refill) — with a February 2026 FDA warning letter you should read first.
MEDVi at a glance
- Semaglutide
- From $179 the first month; no ongoing rate published
- Tirzepatide
- No compounded tirzepatide price on its public page
- Coverage
- No state list on the GLP-1 page
- Brand-name
- Yes
How we scored MEDVi
Each factor is judged from MEDVi's actual pricing, disclosures and support, then combined into the Mama-Match Score of 49/100 using the same weighted six-factor framework we apply to every provider — never influenced by whether a provider pays us.
The start feels transactional — more cash register than welcome.
The cost is unpredictable, hidden behind a quiz, or in the premium range.
Little public detail about who oversees your care, and how.
Coverage is limited or gated behind a signup.
Support is thin once the prescription ships.
Canceling carries real friction — commitments, notice windows or non-refundable charges.
How we verified this review
- Last reviewed
- August 2026
- Confidence
- High
- Primary source
- glp1.medvi.org
The first thing to say is what its site says nowhere: MEDVi, LLC carries an FDA warning letter dated February 20, 2026 for false or misleading claims and a misbranded compounded product. The entity matches the one in its own privacy policy, a Delaware corporation with an address in Newark. That said, it does something almost nobody here does: it names its partner pharmacies with address and phone, and it offers brand medication alongside the compounded product. The published prices — $179 for the injection, $249 for the tablet — are first-month figures; the ongoing rate never appears, and the brand options are sold as $99 membership plus the cost of the medication, on the same page that promises no memberships and no hidden fees. Its marketing copy, too, is line-for-line identical to RxSaludable's.
What to expect when you sign up
We walked MEDVi's public signup (August 2026) — a first-hand look at the process. We did not create accounts, enter medical information, or complete checkout, so this is what any visitor sees, not a patient's outcome.
- 1The GLP-1 page shows "Starting at $179" and "Starting at $249" before asking for anything
- 2The three brand options carry no price: they read "$99 Membership + Medication Cost"
What we noticed
- The published price is the first month's, not the ongoing rate
- Its Terms name the partner pharmacies with address and phone — something most of this list never does
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $179 | Injection, first month"Starting at $179" and "starts at $179 for your first month with no contract." The rate for the months after is not published. |
| Oral semaglutide | $249 | Daily tablet, first month"Starting at $249" for the dissolvable tablet. |
Swipe the table to see plan details →
HSA/FSA is usually accepted for GLP-1 telehealth — check your plan. Prices reflect what MEDVi disclosed publicly at our last review and change often; confirm the current number on MEDVi's site.
What we like
- Names its partner pharmacies with address and phone: Triad Rx in Daphne, Alabama, and RedRock Pharmacy in St. George, Utah
- Names the company in its privacy policy: MEDVi, LLC, a Delaware corporation, in Newark
- Offers FDA-approved brand medication — Wegovy in pill and injection, and Zepbound — alongside the compounded product
- Has an oral route: GLP-1 tablets as well as the injection
- Includes dietitian visits and ongoing support at no extra cost, per its own page
The caveats
- ⛔ FDA warning letter #721455, dated February 20, 2026, to MEDVi, LLC, for false or misleading claims and a misbranded compounded product
- ⛔ Publishes only "from $179" for the first month; the ongoing rate is nowhere on the page
- "No membership or hidden fees!" sits on the same page as three brand options costing "$99 membership + medication cost"
- Its own patient counts contradict each other: "500,000+ patients" in the header and "10,000+ patients" further down
- No state list on the GLP-1 page
- ⚠ Its marketing copy is identical, line for line, to RxSaludable's, testimonials included
MEDVi for moms: our verdict
⛔ Carries an FDA warning letter for a misbranded compounded product (#721455, February 2026). It names its pharmacies with addresses, but publishes only the first month's price. It runs about $179/mo.
We looked at MEDVi the way moms actually have to: not just the monthly cost, but the right timing around pregnancy and nursing and honest, clear pricing from the start — the parts a generic weight-loss review skips.
What MEDVi actually costs
- Compounded semaglutide — Injection, first month: $179/mo
- Oral semaglutide — Daily tablet, first month: $249/mo
That's roughly in line with our list's median of ~$179/mo.
That price covers the consult, the medication, shipping and coaching.
The medications MEDVi prescribes
MEDVi prescribes semaglutide (the active drug in Wegovy and Ozempic). It can point you toward FDA-approved brand-name pens as well as the compounded versions — approved products carry the manufacturer's own pregnancy and breastfeeding label, which is cleaner to hand to an OB-GYN.
There's a needle-free oral or sublingual option on the menu, which appeals to moms who have been putting off injections — just set your expectations: oral and buccal delivery of these peptides is far less studied than the injectable versions used in the trials.
Where it operates. MEDVi publishes no state list, so confirm it serves yours before you pay anything.
Where MEDVi fits — and where it doesn't — for moms
A good fit if…
- the monthly cost is a real barrier and you want a low, predictable number.
Look elsewhere if…
- a clean regulatory record is non-negotiable for you — look at the FDA warning letter flagged in the cons above.
- you'd rather have a clinician talk the timing through with you, with the right timing around pregnancy and nursing in mind — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety and oversight
Our confidence in MEDVi's public data is high — the pricing, the pharmacies and the clinical network were all verifiable at our last review. It has an FDA warning letter, flagged in the cons — read it before you start. As with any compounded GLP-1, the most useful thing moms can do is confirm which licensed pharmacy fills the prescription and what's in the formula — we explain how we score oversight in our scoring methodology.
One line that applies to every provider on this site: no GLP-1 is proven safe during pregnancy or breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the decision about timing is yours and your healthcare provider's.
The bottom line
MEDVi is a provider we list only with the full story attached — weigh it on the right timing around pregnancy and nursing and honest, clear pricing from the start against the alternatives below. For most moms, CoreAge Rx is still the best choice overall — see why it tops our ranking.
The bottom line
Best for: A reader comparing brand access and named pharmacies, who is going to weigh the FDA warning letter before anything else.
Keep comparing MEDVi
Head-to-heads and alternatives
Ranked boards
- Best GLP-1 for moms — a gentle first step
- Best GLP-1 for women — PCOS, cycles, perimenopause
- Best GLP-1 for first-timers (easiest to start)
- Most affordable GLP-1 with honest, clear pricing
- Best semaglutide for mothers — price and practicality
- Best semaglutide for women — compounded vs brand
- Best semaglutide for young moms — postpartum and budget
- Best tirzepatide for mothers — is it worth the extra
- Best tirzepatide for women — PCOS and insulin resistance
- Best GLP-1 with bilingual / Spanish-language support
MEDVi, answered
- How much does MEDVi cost?
- As of our last review, MEDVi's compounded pricing starts around $179/mo (From $179 the first month; no ongoing rate published semaglutide, No compounded tirzepatide price on its public page tirzepatide). Confirm the current all-in price on MEDVi's site before you commit.
- Is MEDVi safe to use while breastfeeding?
- Here is the honest answer: no GLP-1 — compounded or brand-name — is established as safe during pregnancy or breastfeeding, and the labels advise against use; MEDVi is no exception. Plan any GLP-1 for after weaning, and talk the timing through with your own clinician.
- Does MEDVi offer both semaglutide and tirzepatide?
- MEDVi's tirzepatide access is not consistently published; it is primarily a semaglutide program as of our last review. If you specifically want tirzepatide, confirm availability first.
- Where does MEDVi land in your ranking?
- MEDVi scores 49/100 on our Mama-Match Score (rank #218), which weights six things that matter to a first-timer. Our #1 pick, CoreAge Rx, leads the ranking — see how they compare.
Prices, states and verification reflect what MEDVi disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the published methodology. This is gentle background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.